-
Part 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1)
-
Part 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations
-
Part 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2)
-
Part 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
Part 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
Part 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
-
Part 2 | Session 1 Plenary Session 7: New technologies to manage your patients
-
Part 2 | Session 3 Plenary Session 8: New technologies to treat your patients
-
Part 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
-
Part 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Faculty Biographies

Maria Generosa Crespo-Leiro
Prof Crespo-Leiro is the Head of the Heart Failure (HF) and Heart Transplantation (HT) Unit at the Hospital Universitario A Coruña, La Coruña (Spain). Professor of Medicine at the University of Coruña (UDC) in La Coruña (Spain). She obtained her MD at the University of Santiago de Compostela, Specialisation in Cardiology at Clinica Puerta de Hierro in Madrid and PhD from Universidad Autónoma de Madrid.

Ovidiu Chioncel
Professor of Cardiology, Head of ICCU
Dr Ovidiu Chioncel is Professor of Cardiology and Head of ICCU at the University of Medicine Carol Davila in Bucharest, Romania.
His clinical research interests include heart failure, cardiac imaging and emergency medicine.
Dr Chioncel has been involved in numerous clinical trials, and is Director of the Romanian Acute Heart Failure Syndrome registry (RO-AHFS), the National Registry of Acute Aortic Dissections (RENADA) and the National Coordinator of EORP/ESC-HF Registries.
Dr Ovdiu Chioncel is a Section Editor of Cardiac Failure Review.

Alanna Morris
Dr Alanna Morris is Assistant Professor of Medicine at the Department of Medicine, Emory University School of Medicine, US. Dr Morris' research interests include studying the importance of non-modifiable risk factors such as race and gender that may contribute to excess disease in high risk populations, and identifying the role of biomarkers of oxidative stress and endothelial dysfunction in patients with heart failure with reduced ejection fraction.

Shelley Zieroth
Director, Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St Boniface Hospital in Winnipeg, Canada. She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba.
She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She is co-chair of Canada’s largest annual heart failure meeting, HF Update, and Past President of the Federation of Medical Women of Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.

John R Teerlink
Director
Dr John R Teerlink is Director of the Heart Failure Program and of the Clinical Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California.
Dr Teerlink graduated from Swarthmore College with Highest Honors in Comparative Religious Studies and Cellular Biology. After receiving his medical degree from Harvard Medical School, he completed an internal medicine residency at the University of California San Francisco (UCSF).

Gerasimos Filippatos
Professor of Cardiology
Prof Gerasimos Filippatos is a Professor of Cardiology and Cardiologist at National and Kapodistrian University of Athens, Athens, GR.
He studied Medicine at the University of Patras, and earned his doctorate Cum Laude from the University of Athens.
Prof Filippatos is Past President of the Heart Failure Association (HFA) of the European Society of Cardiology and he has published over 600 articles in peer-reviewed journals and authored more than 30 book chapters.